Published on in Vol 9, No 3 (2021): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25406, first published .
Digital Health Integration Assessment and Maturity of the United States Biopharmaceutical Industry: Forces Driving the Next Generation of Connected Autoinjectable Devices

Digital Health Integration Assessment and Maturity of the United States Biopharmaceutical Industry: Forces Driving the Next Generation of Connected Autoinjectable Devices

Digital Health Integration Assessment and Maturity of the United States Biopharmaceutical Industry: Forces Driving the Next Generation of Connected Autoinjectable Devices

Journals

  1. Bittner B. Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology - Analogue-based decision framework. Expert Opinion on Drug Delivery 2023;20(4):457 View
  2. Liaw S, Godinho M. Digital health and capability maturity models—a critical thematic review and conceptual synthesis of the literature. Journal of the American Medical Informatics Association 2023;30(2):393 View
  3. Saxena S, Godfrey T. India’s Opportunity to Address Human Resource Challenges in Healthcare. Cureus 2023 View
  4. Biskupiak Z, Ha V, Rohaj A, Bulaj G. Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases. Journal of Clinical Medicine 2024;13(2):403 View
  5. Machal M. Risks and benefits associated with the primary functions of artificial intelligence powered autoinjectors. Frontiers in Medical Technology 2024;6 View

Books/Policy Documents

  1. Valenzuela-Vallejo L. Translational Sports Medicine. View